Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation (Gen-2), 15 milliamp (mA) neurostimulation device into a new mental health center in Oman, dedicated to the use of…
Elevate Addiction Services Integrates Vivalink Platform for Real-Time Detox Monitoring in Inpatient Treatment
Vivalink, a leading provider of digital healthcare solutions, announces its biometric data platform has been successfully integrated into Elevate Addiction Services’ drug and alcohol in-patient detox treatment program. Vivalink’s Biometrics Data Platform, along with its wearable blood pressure cuff and…
